NCT01416649已完成不适用
Impact of Exenatide on Sleep Duration and Quality in Type 2 Diabetes
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- Sleep duration and sleep efficiency
研究概览
简要总结
This study investigates the effect of exenatide, a FDA approved medication for the treatment of type 2 diabetes on sleep duration and quality. Individuals with type 2 diabetes will be studied before and during treatment with Exenatide.
Enrolled individuals will be asked to come to the University of Chicago for 3-4 outpatient visits over the course of 3-4 months.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients taking diabetes medications other then insulin will be included, but changes to their medications may be made as deemed necessary by their physician. Patients on stable medications for chronic and co-morbid conditions (high blood pressure, high cholesterol, etc) will be eligible
排除标准
- •Patients with moderate or severe kidney disease and history of pancreatitis or patients on insulin will be excluded, as Exenatide use is contraindicated or risky in these conditions.
- •Patients with unstable cardiac, neurological or psychiatric disease and women who are pregnant or trying to get pregnant will be excluded. Patients who have severe COPD, severe neuropathy or chronic pain, which could impair sleep, will be excluded. Shift workers will be also excluded.
结局指标
主要结局
Sleep duration and sleep efficiency
时间窗: at the end of 3 months of treatment with the medication
Sleep duration and efficiency will be measured using an activity monitor worn on the wrist.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Impact of Exenatide on Sleep in Type 2 DiabetesSleep Disordered BreathingType 2 DiabetesNCT01136798University of Chicago18
进行中（未招募）
不适用
Effects of Exenatide on excess daytime sleepiness (EDS), wakefulness and driving performance in obese type-2 diabetes patients without sleep apnea – proof of concept study - exenatide on daytime sleepinesssleepiness and lethargy among obese patients with diabetesMedDRA version: 1Level: LLTClassification code 10012594Term: <Manually entered code. Term in E.1.1>MedDRA version: 1Level: LLTClassification code 10029883Term: <Manually entered code. Term in E.1.1>EUCTR2008-008141-37-GBSherwood Forest Hospitals Foundation Trust
已完成
不适用
The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Sleep Quality.Smoking CessationSleepNCT03603353University of Bern1,246
撤回
4 期
Effect of Dexmedetomidine Upon Sleep PostoperativelySleepNCT00333632Duke University
已完成
4 期
A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill PatientsSleepCritical IllnessNCT00405847University of Arizona17